As of 2025-11-04, the Relative Valuation of Cytokinetics Inc (CYTK) is (130.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 60.03 USD, the upside of Cytokinetics Inc based on Relative Valuation is -316.9%.
The range of the Relative Valuation is (128.60) - (131.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 26.0x | 24.1x |
| Forward P/E multiples | 25.4x - 30.2x | 27.3x |
| Fair Price | (128.60) - (131.84) | (130.22) |
| Upside | -314.2% - -319.6% | -316.9% |
| Date | P/E |
| 2025-11-03 | -11.85 |
| 2025-10-31 | -12.55 |
| 2025-10-30 | -12.29 |
| 2025-10-29 | -12.23 |
| 2025-10-28 | -12.23 |
| 2025-10-27 | -11.88 |
| 2025-10-24 | -11.41 |
| 2025-10-23 | -11.35 |
| 2025-10-22 | -10.81 |
| 2025-10-21 | -11.40 |
| 2025-10-20 | -11.71 |
| 2025-10-17 | -11.53 |
| 2025-10-16 | -11.64 |
| 2025-10-15 | -12.39 |
| 2025-10-14 | -12.04 |
| 2025-10-13 | -11.76 |
| 2025-10-10 | -11.85 |
| 2025-10-09 | -11.90 |
| 2025-10-08 | -12.00 |
| 2025-10-07 | -11.87 |
| 2025-10-06 | -11.97 |
| 2025-10-03 | -11.24 |
| 2025-10-02 | -11.12 |
| 2025-10-01 | -11.02 |
| 2025-09-30 | -10.85 |
| 2025-09-29 | -10.64 |
| 2025-09-26 | -9.95 |
| 2025-09-25 | -9.44 |
| 2025-09-24 | -9.53 |
| 2025-09-23 | -9.58 |
| 2025-09-22 | -9.52 |
| 2025-09-19 | -9.60 |
| 2025-09-18 | -9.73 |
| 2025-09-17 | -9.39 |
| 2025-09-16 | -9.82 |
| 2025-09-15 | -9.76 |
| 2025-09-12 | -10.09 |
| 2025-09-11 | -10.52 |
| 2025-09-10 | -10.26 |
| 2025-09-09 | -10.16 |
| 2025-09-08 | -10.28 |
| 2025-09-05 | -10.46 |
| 2025-09-04 | -9.82 |
| 2025-09-03 | -9.87 |
| 2025-09-02 | -9.79 |
| 2025-08-29 | -6.97 |
| 2025-08-28 | -7.37 |
| 2025-08-27 | -7.47 |
| 2025-08-26 | -7.54 |
| 2025-08-25 | -7.30 |